Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “H. Pancreatic Cancer”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Testing effectiveness (Phase 2)Study completedNCT01553019
What this trial is testing

Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Florida 2
Not applicableNot Yet RecruitingNCT07274657
What this trial is testing

Superb Microvascular Imaging (SMI) and Two-Dimensional Endoscopic Ultrasound Guided Shear Wave Elastography (2D-SWE-EUS) in Differential Diagnosis of Pancreatic Adenocarcinoma (PA) From Other Pancreatic Solid Lesions (PSLs) and Pancreatic neuroendocrinE Tumors (pNETs) Malignancy

Who this might be right for
Pancreas Adenocarcinoma (MSI-H)Pancreatic Neuroendocrine Tumors (pNET)
GCS Ramsay Santé pour l'Enseignement et la Recherche 150
Very early researchNot Yet RecruitingNCT07639970
What this trial is testing

Evaluation of [⁶⁸Ga/¹⁷⁷Lu]HT547: Safety, Biodistribution, and Dosimetry in Solid Tumors

Who this might be right for
Breast CancerHead and Neck Cancer (H&N)Pancreatic Cancer+1 more
Hua Pang 20
Not applicableEnrolling By InvitationNCT04466189
What this trial is testing

Prospective Cohort Study of Pancreatic Cancer Patients Treated With Proton Beam Therapy

Who this might be right for
Pancreas Cancer
National Cancer Center, Korea 120
Not applicableActive Not RecruitingNCT03902600
What this trial is testing

Photon and Proton Chemoradiotherapy as Definitive or Neoadjuvant Therapy in Non-Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Mayo Clinic 103
Not applicableLooking for participantsNCT04894643
What this trial is testing

Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerProton Therapy
EBG MedAustron GmbH 10
Testing effectiveness (Phase 2)Study completedNCT00438256
What this trial is testing

Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Massachusetts General Hospital 50
Early research (Phase 1)Study completedNCT03885284
What this trial is testing

Study of Proton Therapy in Adjuvant Pancreatic Cancer

Who this might be right for
Resected Pancreatic Adenocarcinoma
Georgetown University 9
Not applicableStudy completedNCT00685763
What this trial is testing

Proton Therapy for Unresectable Cancer (CA) of Pancreas

Who this might be right for
Pancreatic Cancer
University of Florida 13
Testing effectiveness (Phase 2)Looking for participantsNCT05093231
What this trial is testing

Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Cambridge University Hospitals NHS Foundation Trust 20
Not applicableStudy completedNCT00763516
What this trial is testing

Proton Radiation for Resectable Carcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
University of Florida 8
Testing effectiveness (Phase 2)UnknownNCT01821729
What this trial is testing

Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Massachusetts General Hospital 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05651022
What this trial is testing

Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultHCC - Hepatocellular CarcinomaCRC (Colorectal Cancer)+5 more
Indaptus Therapeutics, Inc 120
Testing effectiveness (Phase 2)Study completedNCT00001191
What this trial is testing

The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid

Who this might be right for
GastrinomaZollinger Ellison Syndrome
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not applicableUnknownNCT05549414
What this trial is testing

Pivotal Study of Proton Radiotherapy Treatments Using Fixed Beam Chair-Based Delivery System

Who this might be right for
Thoracic CancerPancreatic Cancer Non-resectableBrain Cancer+2 more
P-Cure 100
Testing effectiveness (Phase 2)Ended earlyNCT05251233
What this trial is testing

Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy

Who this might be right for
Pancreatic CancerPancreas CancerAmpullary Cancer+4 more
Washington University School of Medicine 56
Testing effectiveness (Phase 2)Looking for participantsNCT02598349
What this trial is testing

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
Proton Collaborative Group 60
Not applicableStudy completedNCT03949933
What this trial is testing

Proton and Carbon Ion Radiotherapy for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma
Shanghai Proton and Heavy Ion Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT05706129
What this trial is testing

Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)+6 more
ITM Oncologics GmbH 270
Not applicableNot Yet RecruitingNCT07592819
What this trial is testing

A Trial Using Transcriptomic Signatures to Personalize Neoadjuvant Chemotherapy (NAC) for Patients With Resectable Borderline Pancreatic Adenocarcinoma (PDAC)

Who this might be right for
Pancreas Adenocarcinoma (MSI-H)Pancreatic Cancer Resectable
Institut Paoli-Calmettes 367
Load More Results